baber/WOPTO huggingface dataset:
Patent NZ-336245-A (NZ)
Title: Identifying GDNF homologs by incubating in cells expressing c-RET receptors
Inventor: IBANEZ CARLOS
IPC: C07K14/705
Filed: 1996-11-13
Abstract: A competitive assay for identifying compounds that bind to GDNF (neurotrophic factor) receptor comprising: (a) Incubating the compounds with cells that express c-RET receptors in the presence of an excess of labeled 125I-GDNF; (b) Measuring the amount of labeled GDNF bound to the cells; and (c) Comparing the amount labeled GDNF bound to the cells to that of controls not incubated with the compounds.  The cells are selected from NB2/a, MN-1 or PC12 cells.
Patent NZ-504661-A (NZ)
Title: System and method for training a swimmer
Inventor: PENDERGAST DAVID
IPC: A63B71/06
Filed: 1998-10-20
Abstract: A training system and method used to improve the biomechanics, distance per stroke, and aerobic metabolism of a swimmer is disclosed. The system employs a computer interface which allows a coach or a swimmer to input a particular training strategy using pace lights and timing system or, alternatively, using the system's internal training program. The system provides a generator to collect data from a swimmer. A part of the training system is designed to automate the data collection routine while operating in tandem with a swim meter. Another part of the system analyses the swimmers' performance and outputs the appropriate data to the space light controlling circuitry.
Patent NZ-507425-A (NZ)
Title: Mineral flaky filler for composites
Inventor: EFANOVA VERA VASILYEVNA
IPC: C03B32/02
Filed: 1998-04-20
Abstract: A  mineral  flaky filler for composites,  produced  by melting  a  starting  mineral, shaping hard  flaky  vitreous particles  from the melt, and subjecting such  particles  to thermochemical  treatment in an oxidizing  atmosphere  at  a temperature range of 680 to 850 DEG C until at  least  12  % by  weight of the crystal phase and at least 7x1019 spin/cm3 of   reactive  paramagnetic  centers  were  developed,   and followed by air cooling the particles. Such a crystallinity-reactivity balance provides for quality consistent  protective and ornamental coatings on large-size articles  and structures preferably for use in the  tropical climate   and   of  producing  a  filler   that   would   be commercially available.
Patent NZ-509496-A (NZ)
Title: Water mixing unit
Inventor: TURNER MARK RODNEY
IPC: F16K11/087
Filed: 2001-01-23
Abstract: A mixing unit for mixing first and second fluids, comprising: a housing having an inlet for the first fluid, an inlet for the second fluid, and an outlet for a resultant fluid from any flow of first or second fluids, or both; a flow control member within the housing having at least a substantially spherical zone having dedicated for each of the fluids (i) an inlet port, (ii) a passageway leading from the inlet port to (iii) an outlet; and sealing means between the flow control member and the housing.  In use, the flow control member can be rotated to allow issuance of no or either or both fluids from the housing outlet.  Prior to the housing outlet outletting the flow from both passageways (if both) of the flow control member, one flow will have exerted past its passageway outlet a venturi draw in effect on the flow of the other.
Patent NZ-512439-A (NZ)
Title: Pigment dispersant compositions comprising graft copolymers containing acetoacetyl amine pigment anchoring groups
Inventor: SHEAU-HWA MA
IPC: C09D7/45
Filed: 2001-06-18
Abstract: A polymer dispersant for pigments based on an acrylic graft copolymer wherein the graft copolymer has a weight average molecular weight of 3,000 - 100,000 and comprises a polymeric backbone and macro-monomer side chains attached to the back bone, wherein: a) The polymeric backbone is formed of polymerized ethylenically unsaturated monomers; and b) The side chains are macro-monomers that are attached to the backbone at a single terminal point and are formed from polymerized ethylenically unsaturated monomers and have a weight average molecular weight of about 1,000 - 30,000.  Wherein the graft copolymer contains about 2 to 70% by weight, based on the weight of the graft copolymer, of polymerized ethylenically unsaturated monomers containing acetoacetate groups that are polymerized into the backbone, side chains, or both, and the acetoacetate groups are reacted with a primary amine to form a pendent acetoacetyl amine group on the graft copolymer which serves as the pigment anchoring group.  These materials are effective in dispersing and stabilizing a wide range of pigments in solvent based systems and are particularly useful in forming pigment dispersions that are used in a variety of solvent borne coating compositions for automobiles and trucks, where they provide improved efficiency of pigment use, lower paint viscosity, and reduced emission of volatile organic solvent.
Patent NZ-512456-A (NZ)
Title: Ordered molecular presentation of antigens
Inventor: HENNECKE FRANK
IPC: C12N7/01
Filed: 1999-11-30
Abstract: A composition useful in the production of vaccines comprising: a) a non-naturally occurring molecular scaffold comprising: i) a core particle selected from the group consisting of: a core particle of non-natural origin; and a core particle of natural origin; and ii) an organizer comprising at least one first attachment site, wherein said organizer is connected to said core particle by at least one covalent bond; and b) an antigen or antigenic determinant with at least one second attachment site, said second attachment site being selected from the group consisting of: i) an attachment site not naturally occurring within said antigen or antigenic determinant; and ii) an attachment site naturally occurring within said antigen or antigenic determinant, wherein said second attachment site is capable of association through at least one non=peptide bond to said first attachment site; and wherein said antigen or antigenic determinant and said scaffold interact through said association to form an ordered and repetitive antigen array. Also covered is a process for producing said composition, and a method of veterinary treatment of non-human animals comprising the administration of said composition to a non- human animal.
Patent NZ-516698-A (NZ)
Title: Bryostatins, bryopyrans and polyketides: compositions and methods
Inventor: HILDEBRAND MARK
IPC: C12P17/08
Filed: 2000-08-04
Abstract: A composition comprising an isolated nucleic acid molecule encoding a polypeptide that catalyses a step in the synthesis of a bryopyran ring, said nucleic acid molecule being derived from an invertebrate marine organism or symbiont, and wherein the polypeptide comprises a beta- ketoacyl synthase domain. Also disclosed is the use of said composition in a method for making a polyketide or bryopyran ring.
Patent NZ-517538-A (NZ)
Title: Drug for treating fractures
Inventor: LITTLE DAVID GRAHAM
IPC: A61P19/00
Filed: 2000-08-17
Abstract: A drug selected from the group consisting of at least one bisphosphonate for the manufacture of a medicament for use in treating bone fractures.
Patent NZ-518484-A (NZ)
Title: Control of paint skinning
Inventor: HADDAD AZIZ GEORGE
IPC: B44D3/12
Filed: 2000-11-03
Abstract: A container for water based paints, the container comprising: i) a container body moulded from plastics material; and ii) a container closure moulded from plastics material; wherein at least a part of the inner surface of either the container body or container closure has a coating applied thereto to control the contamination of the paint by reducing paint skin or thickened paint falling from the coating into the body of the paint. The coating may be applied during the container manufacturing process or during the process of packaging paint in the container.
Patent NZ-520426-A (NZ)
Title: A hydraulic cement comprising a reactive magnesium oxide
Inventor: HARRISON AUBREY JOHN WESTON
IPC: C04B24/24
Filed: 2001-01-29
Abstract: A hydraulic cement composition includes reactive magnesium oxide at a level of at least 5% w/w of hydraulic cementitious components in the composition excluding pozzolans only from the calculation of the percentage of reactive magnesium oxide. The magnesium oxide is prepared by low temperature calcinations and fine grinding, and the hydraulic cementitious components exclude magnesium oxychlorides and magnesium oxysulfates and with the proviso that the term reactive magnesium oxide excludes magnesium oxide sourced from dolomite.
Patent NZ-521210-A (NZ)
Title: Method for the treatment or prevention of flavivirus infections using nucleoside analogues
Inventor: ALAOUI-ISMAILI MOULAY-HICHAM
IPC: A61K38/00
Filed: 2001-02-19
Abstract: The use of a therapeutically effective amount of a compound having the formula Ib or a pharmaceutically acceptable salt thereof in the manufacture of a medicament for the treatment or prevention of a Flavivirus infection or a hepatitis C infection in a host.
Patent NZ-521404-A (NZ)
Title: Method for maintaining progesterone plasma levels
Inventor: BUNT CRAIG ROBERT
IPC: A61M31/00
Filed: 1998-01-30
Abstract: A method for delivering progesterone to a non-human target species is described. The method includes inserting into the mammal an intra-vaginal device capable after insertion of releasing or being caused to release the progesterone. The device allows over an insertion period a release of: - A dose rate of about 70mg/day of progesterone - A delivery rate of about 1.6 mL/day of a progesterone composition - A pump rate of about 0.07 mL/hour of a progesterone composition.
Patent NZ-529553-A (NZ)
Title: An improved lock including anti jemmying features
IPC: E05B17/20
Filed: 2003-11-14
Abstract: A lock assembly (10) for use in a door stile (16), said stile (16) having a cavity (18) defined in part by a rear wall (22), said assembly (10) including: a front face and a generally parallel spaced apart rear face; a slidable bolt (36) adapted to move inwardly and outwardly of said front face; said rear face substantially parallel to and spaced apart from said rear wall (22); at least one tab (48a, 48b) substantially thinner than said lock assembly (10) and extending from said lock assembly (10) rear face towards said rear wall (22).
Patent NZ-531035-A (NZ)
Title: Human mini-antibody cytotoxic for tumor cells which express the ErbB2 receptor
Inventor: D ALESSIO GIUSEPPE
IPC: C12N1/21
Filed: 2002-07-10
Abstract: A recombinant single chain anti-ErbB2 antibody of human origin able to inhibit growth of cells expressing the ErbB2 receptor; nucleotide sequences encoding the recombinant antibody; vector and bacteriophage comprising the nucleotide sequences; pharmaceutical composition comprising the antibody; the use of the composition in the preparation of anti-proliferative and anti-tumor drugs; and process for the preparation of the bacteriophage.
Patent NZ-533848-A (NZ)
Title: Detection of mutations in the flavin-containing monooxygenase (FMO3) gene
Inventor: LUNDEN ANNE
IPC: C12N9/02
Filed: 2003-01-09
Abstract: A polypeptide which is a flavin-containing monooxygenase 3 (FMO3) comprising at least a sequence that has at least 85% identity with the polypeptide sequence SEQ ID NO:15. Also described is an isolated nucleic acid comprising the polypeptide, a set of primers for amplifying the nucleic acid and methods for detecting a mutation in the FMO3 gene of an animal.
Patent NZ-534439-A (NZ)
Title: Latch mechanism for pivoting handle assembly of a power tool
Inventor: STONES KEVIN
IPC: H01H3/36
Filed: 2004-07-30
Abstract: A latch mechanism for a power tool such as a hedge trimmer having a housing accommodating a motor and a handle assembly adapted to pivot relative to the housing between a plurality of positions is disclosed. The latch mechanism includes a lever ( 210 ) carrying a first retaining member ( 181 ) for movement relative to the housing between an engaging condition to engage the handle assembly to releasably retain the housing relative to the handle assembly, and a retracted condition for allowing pivotal movement of the housing relative to the handle assembly. A second retaining member ( 182 ) is movable relative to the housing ( 103 ) between an engaging position to engage the handle assembly to releasably retain the housing ( 103 ) in position relative to the handle assembly, and a retracted condition for allowing pivotal movement of the housing relative to the handle assembly. The retaining members ( 181 ), ( 182 ) are biased towards their engaging conditions by means of a spring ( 186 ). An interlock member ( 214 ) on lever ( 210 ) cooperates with an arm member ( 163 ) to prevent disengagement of the first ( 181 ) and second ( 182 ) retaining members from the handle assembly when the motor is actuated, and for preventing actuation of the motor when the first ( 181 ) or second ( 182 ) retaining member is in a retracted condition.
Patent NZ-534866-A (NZ)
Title: Means and methods for the production of adenovirus vectors
Inventor: VOGELS RONALD
IPC: A61P31/14
Filed: 2003-04-24
Abstract: Described is a recombinant adenovirus vector comprising structural and non-structural elements of an adenovirus of a first serotype, wherein the vector further comprises a sequence encoding a functional E4-orf6 protein, or a functional part, derivative and/or analogue thereof, wherein said sequence is selected from the group consisting of: 1. an E4-orf6 encoding sequence derived from an adenovirus of a second serotype different from said first serotype; 2. an E4-orf6 encoding sequence derived from an adenovirus of said first serotype comprising a deletion, mutation, addition and/or substitution in one or more codons; and 3. an E4-orf6 encoding sequence comprising a fusion between a part of an E4-orf6 encoding sequence derived from a second serotype different from the first serotype and a part of an E4-orf6 encoding sequence derived from a third serotype, wherein
Patent NZ-536039-A (NZ)
Title: Castellated wood beam and method of its manufacture
IPC: E04C3/17
Filed: 2004-10-20
Abstract: A castelled beam comprising a first beam section having a cut line pattern defining a plurality of first beam section lands and grooves. A second beam section has a cut line pattern defining a plurality of second beam section lands and second beam section grooves, the first beam section lands being connected with the second beam section lands. The castelled beam contains wood.
Patent NZ-543249-A (NZ)
Title: Low drag submerged asymmetric displacement lifting body
Inventor: LOUI STEVEN
IPC: B63B1/24
Filed: 2004-04-30
Abstract: A three-dimensional low drag underwater lifting body for operation in a submerged state has a continuous leading edge, a fore-and-aft axis 33, and an outer surface conforming in plan view on one side of the axis to a parabolic curve 20b and on the other side of the axis to a non-symmetric shape including another parabolic curve 22a, the vertices of both of which lie on the leading edge, and in longitudinal cross-sectional planes parallel to the axis, to parabolic foil curves having vertices lying on the leading edge and which extend aft predetermined distances. The thickness to the parabolic cross-sectional foils decreases on either side of the axis of the lifting body to the leading edge of the lifting body. The lifting body or several of them is attached by struts to the underside or beside the main hull of a vessel to provide both buoyant and hydrodynamic lift.
Patent NZ-549286-A (NZ)
Title: Package for cigarette rolling paper
Inventor: BOBE CARLOS PORTELLA
Filed: 2006-08-21
Abstract: A package for cigarette rolling paper is disclosed. The package is made up of a die cut and folded sheet (1), making up a noticeably prismatic shaped rectangle with some slots (18) for the extraction of the cigarette rolling papers (21) stored in two or more wads (2) of paper (21), respectively folded and fitted in a zigzag fashion. The wads of paper (2) are housed on the inside of the package and are supported on a reinforcing card (3) placed on the inner surface of the lower wall (14) of the package. The reinforcing card (3) has at least two tabs (31) to retain the wads of paper (2) and which is placed between the wads of paper (2), oriented towards the upper area, respectively inclined towards the front and rear walls of the package, and hinged on both fold lines coinciding with a longitudinal X-X axis, parallel to the wads of paper (2) and the slots (18) for the extraction of the sheets of paper (21).
Patent NZ-553223-A (NZ)
Title: Cross cutting apparatus with enhanced timber support and compound bevel facility
Inventor: ROBERTSON CLYDE MAXWELL
Filed: 2007-02-15
Abstract: A timber cross cutting apparatus includes a pair of opposed saws reciprocating along a main axis to cross cut timber feed into the corridor orthogonal to the main axis via opposed drive units. The drive units which can be raised and lowered and moved along the main frame to keep the timber centred through the corridor are provided with arms extending as close as practical into the region that might be occupied by the saw blades without extending into that region, the arms being provided with drive chains or belts and opposed pressure rollers to drive the timber through the corridor and rollers to support the timber. The saws can be pivoted on the main axis to provide for angled cuts, and the drive units can also be pivoted on the axis of the corridor, which in combination with pivoting of the saws, allows compound bevel cuts to be made.
Patent NZ-555624-A (NZ)
Title: Spirotropane compounds and methods for the modulation of CCR5 chemokine receptor activity
Inventor: CHAN CHUN KONG LAVAL
IPC: C07D471/20
Filed: 2005-12-09
Abstract: Spirotropane compounds according to formula (I): wherein the variables are as herein defined in the specification, and wherein ring A represents a 5 or 6 membered heteroring substituted once or twice with a keto substituent. These compounds and their pharmaceutical acceptable salts are used in combinations or in pharmaceutical compositions and are suitable for the modulation of CCR5 chemokine receptor activity.
Patent NZ-555751-A (NZ)
Title: Valved male luer connector having sequential valve timing
Inventor: DOYLE MARK C
IPC: A61M39/10
Filed: 2005-12-01
Abstract: A male Luer connector 200 attaches to a female Luer connector with a front contact surface and an internal valve, to open a medical fluid flow channel between the two connectors. The male connector has two internal valves 206, 208 and a vacuum-generating structure 212, 210. The two valves and the vacuum-­ generating structure are configured to draw back into the male connector any fluid residing on the interface between the connectors during their disengagement and to then seal the distal tip of the male connector. Both valves are opened/closed by a movable actuator plug 224 by contact with the front surface of the female connector. A resilient member 210 biases the male valves to the closed position and includes a variable internal volume 212 that creates the vacuum upon disengagement of the connectors. The male valves are timed to a particular sequence with the closing of an internal female connector valve so that the vacuum generated by the male connector will have the most fluid drawback effect.
Patent NZ-563397-A (NZ)
Title: Antifungal agents comprising indolizinyl derivatives
Inventor: THOMSON SAMANTHA PATRICIA
IPC: A61K31/437
Filed: 2006-05-18
Abstract: Use of a compound which is an indolizinyl derivative formula (I), or a pharmaceutically acceptable salt thereof, for the manufacture of a medicament for the prevention or treatment of a fungal disease, wherein the variables are defined in the specification. Also disclosed is a method of controlling a fungal disease in a plant, comprising applying said derivative, compounds of formula (I) and a pharmaceutical composition comprising compounds of formula (I).
Patent NZ-564703-A (NZ)
Title: Method and arrangement for triggering a series spark gap
Inventor: HALLSTROM JARI
IPC: H02H9/06
Filed: 2006-06-29
Abstract: A method and arrangement for triggering a spark gap is disclosed. A series spark gap is triggered such that in parallel with partial spark gaps (1, 2) of the series spark gap there are coupled first voltage distribution means. Further, at least in one partial spark gap (1, 2) there is arranged an additional electrode (10) whose voltage is set to a given level by means of second voltage distribution means. The voltage level of the additional electrode (10) is changed by disturbing the voltage distribution of the second voltage distribution means. Thus the spark gap between the main electrode (6a, 6b) of the partial spark gap (1) and the additional electrode (10) will be ignited. Capacity of the second voltage distribution means is lower than that of the first voltage distribution means and consequently the voltage acting over the first voltage distribution means does not change significantly. Thus the voltage determined by the first voltage distribution means acts over the spark gap that is between the additional electrode (10) and the second main electrode (6a, 6b) of the partial spark gap (1) and that will also ignite, which further results in the supply voltage (U) acting only over the second partial spark gap (2), whereby a spark-over will also occur therein.
Patent NZ-569395-A (NZ)
Title: Injection device with a capacitive proximity sensor including an elextrode with a concave shape
Inventor: LAUCHARD GERHARD
IPC: A61M5/20
Filed: 2007-01-30
Abstract: Disclosed is an injection device for injecting medication to a patient with increased security of use. The device comprises a surface (5) having a through hole (3) for passage of a needle (a), and a capacitive proximity sensor for detecting proximity to or contact of human skin with the surface. The sensor comprises an electrode, one side of which is adjacent to the through hole, the electrode having a concave shape (6) that follows part of the contour of the through hole.
Patent NZ-571620-A (NZ)
Title: Pharmaceutical composition comprising anti-miRNA antisense oligonucleotides
Inventor: ELMEN JOACIM
IPC: A61P3/10
Filed: 2007-03-30
Abstract: Disclosed is a single stranded oligonucleotide having a length of 8 to 26 nucleobase units, wherein the oligonucleotide has a sequence comprising a core DNA sequence of 3' - ctcaca -5' (SEQ ID NO 7) from positions two to seven or from positions three to eight thereof counting from the 3' end of said oligonucleotide, and wherein said oligonucleotide comprises at least one phosphorothloate internucleoside linkage, and at least one LNA unit optionally positioned within said core DNA sequence, such that an LNA unit positioned within said core DNA sequence is a corresponding LNA unit to a DNA unit of said core DNA sequence. Also disclosed is the use of the single stranded oligonucleotide In the preparation of a medicament for treatment of a disease or medical disorder selected from the group consisting of increased plasma cholesterol level, atherosclerosis, hypercholesterolemia, hyperlipidemia, Hepatitis C, cancer, and a metabolic disorder.
Patent NZ-574974-A (NZ)
Title: Method of controlling a milking implement, a software program for and an implement performing the method
Inventor: VAN DEN BERG KAREL
IPC: A01J5/017
Filed: 2007-08-28
Abstract: Disclosed in a method of controlling a milking implement for automatically milking a dairy animal the milking implement comprises a camera (100) and a teat cup (28). The method comprises the following steps: · Attaching the teat cup (28) to a teat of the udder (47) · Producing by means of the camera an image of at least a part of the udder (47) and of at least a part of the teat cup (28) · Making an analysis of the image of the udder (47) with the teat cup (28) using a control system and, · Performing at least one control action by means of the milking implement based on the analysis. The step of making the analysis comprises analysing a manner in which the teat (46) is received in the teat cup (28). The analysis is made of a part of the teat (46) that is located between the teat cup (28) and the udder (47) using the control system.